Skip to main content

Table 7 Relationship of interaction between rs2151280 and smoking with lung cancer risk and NSCLC

From: Association between polymorphism in CDKN2B-AS1 gene and its interaction with smoking on the risk of lung cancer in a Chinese population

 

Controls (%)

Smoking

 

Lung Cancer

 

Non-small cell lung cancer

  
   

Cases (%)

OR (95%CI)

P value

ORª (95%CI)

Pa value

Cases (%)

OR (95%CI)

P value

ORª (95%CI)

Pa value

CC

75 (13.8)

Never

31 (6.1)

1.00 (ref)

   

25 (6.4)

1.00 (ref)

   

TC+TT

401 (74.0)

Never

259 (51.1)

1.563 (1.000–2.443)

0.050

1.659 (1.056–2.606)

0.028

194 (49.4)

1.451 (0.894–2.355)

0.131

1.559 (0.956–2.542)

0.075

CC

9 (1.7)

Ever

25 (4.9)

6.72 (2.818–16.029)

< 0.001

9.392 (3.849–22.914)

< 0.001

19 (4.8)

6.333 (2.541–15.784)

< 0.001

8.42 (3.296–21.510)

< 0.001

TC+TT

57 (10.5)

Ever

192 (37.9)

8.149 (4.882–13.604)

< 0.001

11.442 (6.626–19.761)

< 0.001

155 (39.4)

8.158 (4.73–14.07)

< 0.001

10.905 (6.100–19.495)

< 0.001

  1. OR odds ratio, CI confidence interval, NSCLC non-small-cell lung cancer
  2. aAdjusted for age, gender, and smoking